ECM
ONC

ETrade Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

ETrade Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$981K Sell
3,425
-434
-11% -$102K 0.02% 383
2020
Q2 		$727K Buy
+3,859
New +$628K 0.02% 450

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ETrade Capital Management's ONC Position: Q3 2020 in Review

ETrade Capital Management reduced its BeOne Medicines Ltd (ONC) stake by 11% in Q3 2020, selling an estimated $102K and leaving 3,425 shares worth $981K. The position accounts for 0.02% of the portfolio, ranked #383.

ETrade Capital Management first reported a position in ONC in Q2 2020 and has held it in 2 quarters since. 244 funds tracked by Wall St. Rank hold ONC as of Q3 2020.

  • ETrade Capital Management held 3,425 shares of BeOne Medicines Ltd worth $981K as of Q3 2020.
  • ETrade Capital Management sold 434 BeOne Medicines Ltd shares in Q3 2020, an estimated $102K.
  • BeOne Medicines Ltd made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #383 holding.
  • ETrade Capital Management first reported a position in BeOne Medicines Ltd in Q2 2020 and has held it in 2 quarters since.
  • 244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.